Wikisage, the free encyclopedia of the second generation, is digital heritage

Etifoxine: Difference between revisions

From Wikisage
Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 16: Line 16:
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364751/pdf/pone.0120473.pdf do Rego JL, Vaudry D, Vaudry H (2015) The Non-Benzodiazepine Anxiolytic Drug Etifoxine Causes a Rapid, Receptor-Independent Stimulation of Neurosteroid Biosynthesis. PLoS ONE 10(3): e0120473. doi:10.1371/journal.pone.0120473]
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364751/pdf/pone.0120473.pdf do Rego JL, Vaudry D, Vaudry H (2015) The Non-Benzodiazepine Anxiolytic Drug Etifoxine Causes a Rapid, Receptor-Independent Stimulation of Neurosteroid Biosynthesis. PLoS ONE 10(3): e0120473. doi:10.1371/journal.pone.0120473]
<references/>
<references/>
[[Category:GABAA receptor positive allosteric modulators]]

Revision as of 19:09, 5 August 2016

Choi, YM, and Kim, KH (2015). Etifoxine for Pain Patients with Anxiety

etifoxine is an anticonvulsant and ansiolytic agent. It is not recommended under the age of 18 years.[1]

The known mechanism oof action is potentiation of GABAA receptor, via stimulation of neurosteroid production. The etifoxine therapy promoted the regeneration of axons [2] [3]

Links

Etifoxine promotes glial‑derived neurotrophic factor‑induced neurite outgrowth in PC12 cells

do Rego JL, Vaudry D, Vaudry H (2015) The Non-Benzodiazepine Anxiolytic Drug Etifoxine Causes a Rapid, Receptor-Independent Stimulation of Neurosteroid Biosynthesis. PLoS ONE 10(3): e0120473. doi:10.1371/journal.pone.0120473